Abcuro

BioTech/Drugs - Newton, MA, US

Abcuro Details

Abcuro is a clinical stage biotechnology company developing treatments for autoimmune and cancer indications modulated by cytotoxic T and NK cells that express the inhibitory immune checkpoint receptor KLRG1 (killer cell lectin-like receptor G1). The company is advancing ABC008, a first-in-class anti-KLRG1 antibody designed to deplete cytotoxic T cells that attack healthy muscle tissue in patients with inclusion body myositis (IBM), into clinical studies. IBM is a progressive and debilitating inflammatory skeletal muscle condition with no available pharmaceutical therapies. Abcuro has received FDA orphan drug designation for ABC008 in IBM. The company is also advancing ABC015, an anti-KLRG1 blocking antibody capable of reactivating inhibited cytotoxic T and NK cells in the tumor microenvironment.

Abcuro logo, Abcuro contact details
Website: abcuro.com
Employees: 20 - 49
HQ: 617-714-9759
Location: Newton, MA, US
Revenue: 2.5 - 5 Million
N/A
Abcuro Technologies
E-commerce Platforms

Woo Commerce

Email Providers

Outlook

Load Balancers

Apache

CMS

WordPress.org

Hosting

GoDaddy Hosting

Other

Mobile Friendly

View All Technologies Used At Abcuro

Contacting Abcuro: Connect with Executives and Employees

Get in Touch with Abcuro Executives and Employees

Connecting with Abcuro's Executives and Workforce

Accessing Contact Information for Abcuro Executives

Connecting with Abcuro: Reach Out to Their Team

Discover How to Contact Abcuro Executives and Staff

Looking to connect with Abcuro executives or employees?

Seeking to Get in Touch with Abcuro Executives or Staff?

Want to Reach Out to Abcuro Executives or Team Members?

In Search of Contact Details for Abcuro Professionals?

Connecting with Abcuro: Contacting Executives and Staff

Browse companies
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z